Download click here

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Venetia Bourrier
In 1990 Venetia became the Director of Pharmacy at the Manitoba
Cancer Treatment & Research Foundation, now known as
CancerCare Manitoba (CCMB).
Over the next 20 years, Venetia developed a comprehensive
oncology pharmacy program at CCMB. Major accomplishments
include establishment of a chemotherapy ordering process, investigational drug
service, a Regional Oncology Pharmacy and Therapeutics committee, an
intravenous admixture pharmacy service, an ambulatory infusion pump program
and electronic prescribing.
Intravenous (IV) chemotherapy has always been a high risk intervention of
patients. Adverse events, including the death of a patient due to fluorouracil
overdose, have highlighted the safety risk inherent with this drug therapy. Since
2007, Venetia has been very involved in patient safety efforts at both the
provincial and national level in several initiatives aimed at improving the practice
of all healthcare providers to minimize risk to patients.
Venetia is the Interim Director of the Quality, Patient Safety and Risk program at
CCMB where she practices each and every day to effect changes to support
increased safety for oncology patients.
Venetia is a very deserving recipient of this first ever Manitoba Pharmaceutical
Association Patient Safety Award.